These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a. Saito H, Tomioka H, Sato K, Dekio S. Antimicrob Agents Chemother; 1994 Dec; 38(12):2877-82. PubMed ID: 7695276 [Abstract] [Full Text] [Related]
28. In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis. Ji B, Truffot-Pernot C, Grosset J. Tubercle; 1991 Sep; 72(3):181-6. PubMed ID: 1663283 [Abstract] [Full Text] [Related]
36. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods. Trimble KA, Clark RB, Sanders WE, Frankel JW, Cacciatore R, Valdez H. J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096 [Abstract] [Full Text] [Related]
39. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis]. Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J. Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726 [Abstract] [Full Text] [Related]
40. [In vitro antimycobacterial activity of a new quinolone, T-3761]. Tomioka H, Sato K, Saito H. Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]